FDA Proposes Withdrawing Tavneos: Should Patients Stop Taking It?
The FDA has proposed withdrawing Tavneos, but it has not ordered an immediate recall. For patients with ANCA-associated vasculitis, the key step right now is to contact the prescribing specialist before stopping, switching, or delaying treatment.
